Werewolf Therapeutics Inc (HOWL)

NASDAQ
18.31
-1.68(-8.40%)
  • Volume:
    38,793
  • Bid/Ask:
    16.00/23.52
  • Day's Range:
    18.18 - 19.74

HOWL Overview

Prev. Close
19.99
Day's Range
18.18-19.74
Revenue
-
Open
19.74
52 wk Range
11.23-23.99
EPS
-
Volume
38,793
Market Cap
504.76M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
-
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
27,567,644
Next Earnings Date
Dec 01, 2021
What is your sentiment on Werewolf Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Werewolf Therapeutics Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellSellBuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyBuy
SummaryStrong SellStrong SellStrong SellStrong BuyStrong Buy

Werewolf Therapeutics Inc Company Profile

Werewolf Therapeutics Inc Company Profile

Sector
Services
Employees
28

Werewolf Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing a pipeline of cancer treatments. It is developing immuno-stimulatory therapeutics designed to act selectively within the tumor microenvironment to enhance the body’s immune response to cancer. Its PREDATOR platform is design to conditionally activate molecules that stimulate both adaptive and innate immunity with addressing the limitations of conventional proinflammatory immune therapies. The INDUKINETM molecules, is intended to selectively target the tumor microenvironment (TME). PREDATOR platform consists of protein engineering technologies which is used to generate INDUKINE molecules with multiple functional domains rationally engineered into a single protein to achieve the pharmaceutical profile. The Company using PREDATOR platform, have developed three initial product candidates: WTX-124, WTX-330 and WTX-613.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.